Plain-English translation of NCT06883201 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study is testing whether treating low blood iron levels before breast cancer surgery can reduce the need for blood transfusions. Breast cancer patients often have low blood counts before surgery, which sometimes requires transfusions during the operation. This trial uses ferric carboxymaltose, an iron medication given by IV, to build up blood levels beforehand and see if that reduces transfusion needs.
Many breast cancer patients arrive at surgery with anemia (low blood counts), which often leads to blood transfusions that carry their own risks. This trial exists to find out whether treating iron deficiency before surgery with this medication can prevent transfusions and improve overall outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have blood tests before surgery to check your blood count, iron levels, and vitamin B12 and folate levels. If any deficiencies are found, you will receive iron treatment by IV injection before your scheduled surgery. The study team will monitor your blood levels throughout this time to ensure the treatment is working well and prepare you for surgery with the best possible blood health.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Italy
Sponsor
Regina Elena Cancer Institute
Collaborators
Campus Bio-Medico University, Umberto I Hospital, Frosinone Italy
Enrollment target
~78 participants
Started
January 2023
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giuseppina A. Natale, Doctor
Regina Elena Cancer Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.